Syra Health Corp
SYRA· OTC
SYRASyra Health Corp
Filed Aug 8, 2024 · 10-Q · 39 days after period end · 0001493152-24-030756
| Metric | Q2 2024 | Q2 2023 |
|---|---|---|
| Revenue | $1.97M | $979.25K |
| Net Income | -$1.39M | -$802.80K |
| EPS Diluted | -$0.21 | -$0.18 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Syra Health Corp · CIK 1922335 · Engraved from SEC EDGAR
ended Jun 30, 2024 · filed Aug 8, 2024 · 39 d after period end
